Most recent by Michael Keating, MD
SPONSORED CONTENT
May 10, 2008
6 min read
Save
Nilotinib: a second generation tyrosine kinase inhibitor for the treatment of CML
Chronic myeloid leukemia is a hematologic stem-cell disorder characterized by excessive proliferation and reduced apoptosis of cells of the myeloid lineage.